HOME BANCSHARES INC's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), HOME BANCSHARES INC reported net income of $475.4M (+18.2% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Loans | $1.1B | $1.1B | $989.6M | $728.3M |
| Taxable | $106.1M | $125.8M | $138.6M | $91.9M |
| Tax-exempt | $30.9M | $31.0M | $31.6M | $28.4M |
| Deposits – other banks | $26.2M | $42.8M | $15.0M | $29.1M |
| Federal funds sold | $205.0K | $255.0K | $221.0K | $25.0K |
| Total interest income | $1.3B | $1.3B | $1.2B | $877.8M |
| Interest on deposits | $347.0M | $376.6M | $296.0M | $86.0M |
| Federal funds purchased | $0 | $1.0K | $3.0K | $2.0K |
| FHLB and other borrowed funds | $21.8M | $52.5M | $30.8M | $11.1M |
| Securities sold under agreements to repurchase | $4.1M | $5.4M | $4.8M | $1.4M |
| Subordinated debentures | $13.6M | $16.5M | $16.5M | $20.6M |
| Total interest expense | $386.5M | $451.0M | $348.1M | $119.1M |
| Net interest income | $892.4M | $848.8M | $826.9M | $758.7M |
| Provision for credit losses on loans | $24.1M | $48.4M | $11.9M | $50.2M |
| Recovery of credit losses on unfunded commitments | ($1.0M) | — | — | — |
| (Recovery of ) provision for credit losses on investment securities | ($2.2M) | ($330.0K) | — | — |
| Total credit loss expense | $20.9M | $48.1M | $12.1M | $63.6M |
| Net interest income after provision for credit losses | $871.5M | $800.7M | $814.8M | $695.1M |
| Service charges | $86.8M | $82.2M | $83.4M | $81.7M |
| Trust fees | $19.7M | $18.7M | $17.9M | $12.9M |
| Mortgage lending income | $17.8M | $15.8M | $10.7M | $17.7M |
| Insurance commissions | $2.2M | $2.2M | $2.1M | $2.2M |
| Increase in cash value of life insurance | $6.1M | $4.8M | $4.7M | $3.8M |
| Dividends from FHLB, FRB, FNBB & other | $10.7M | $11.5M | $11.6M | $9.2M |
| Gain on sale of SBA loans | $642.0K | $617.0K | $278.0K | $183.0K |
| Gain on branches, equipment and other assets, net | $754.0K | $2.1M | $1.5M | $15.0K |
| (Loss) gain on OREO, net | ($161.0K) | ($2.3M) | $332.0K | $500.0K |
| Fair value adjustment for marketable securities | $2.4M | $3.0M | ($1.1M) | ($1.3M) |
| Other income | $51.7M | $30.0M | $38.5M | $48.3M |
| Total non-interest income | $198.5M | $168.6M | $169.9M | $175.1M |
| Salaries and employee benefits | $252.9M | $241.0M | $257.0M | $238.9M |
| Occupancy and equipment | $57.7M | $58.0M | $60.3M | $53.4M |
| Data processing expense | $34.4M | $36.5M | $36.3M | $34.9M |
| Merger and acquisition expenses | $580.0K | $0 | $0 | $49.6M |
| Other operating expenses | $112.6M | $111.4M | $119.3M | $98.8M |
| Total non-interest expense | $458.2M | $446.9M | $472.9M | $475.6M |
| Income before income taxes | $611.8M | $522.3M | $511.9M | $394.6M |
| Income tax expense | $136.4M | $120.1M | $119.0M | $89.3M |
| Net income | $475.4M | $402.2M | $392.9M | $305.3M |
| Basic earnings per common share (in dollars per share) | $2.41 | $2.01 | $1.94 | $1.57 |
| Diluted earnings per common share (in dollars per share) | $2.41 | $2.01 | $1.94 | $1.57 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Loans | $298.1M | $273.5M | $283.2M | $276.0M |
| Taxable | $25.8M | $24.7M | $26.3M | $26.4M |
| Tax-exempt | $7.8M | $7.8M | $7.7M | $7.6M |
| Deposits – other banks | $5.1M | $4.9M | $6.2M | $9.0M |
| Federal funds sold | $37.0K | $48.0K | $56.0K | $53.0K |
| Total interest income | $336.8M | $311.0M | $323.5M | $319.1M |
| Interest on deposits | $87.4M | $79.1M | $88.0M | $88.5M |
| FHLB and other borrowed funds | $4.3M | $4.7M | $5.4M | $5.5M |
| Securities sold under agreements to repurchase | $1.1M | $927.0K | $1.0M | $1.0M |
| Subordinated debentures | $2.4M | $2.4M | $3.0M | $4.1M |
| Total interest expense | $95.2M | $87.1M | $97.4M | $99.2M |
| Net interest income | $241.6M | $223.9M | $226.2M | $220.0M |
| Provision for credit losses on loans | $5.2M | $1.5M | $6.7M | $3.0M |
| Recovery of credit losses on unfunded commitments | $0 | ($1.0M) | — | $0 |
| Total credit loss expense | $5.2M | $500.0K | $3.5M | $3.0M |
| Net interest income after credit loss expense | $236.4M | $223.4M | $222.7M | $217.0M |
| Service charges | $23.0M | $19.8M | $22.6M | $22.2M |
| Trust fees | $6.1M | $5.5M | $4.6M | $5.2M |
| Mortgage lending income | $5.1M | $4.4M | $4.7M | $4.8M |
| Insurance commissions | $578.0K | $536.0K | $574.0K | $589.0K |
| Increase in cash value of life insurance | $1.6M | $1.4M | $1.4M | $1.4M |
| Dividends from FHLB, FRB, FNBB & other | $2.8M | $2.5M | $2.7M | $2.7M |
| Gain on sale of SBA loans | $0 | $80.0K | $46.0K | $0 |
| Gain (loss) on sale of branches, equipment and other assets, net | $3.0K | ($7.0K) | ($66.0K) | $972.0K |
| Gain (loss) on OREO, net | $332.0K | $707.0K | ($1.0K) | $13.0K |
| Fair value adjustment for marketable securities | $817.0K | ($1.2M) | $1.0M | ($238.0K) |
| Other income | $13.1M | $9.1M | $14.0M | $13.5M |
| Total non-interest income | $53.5M | $42.8M | $51.5M | $51.1M |
| Salaries and employee benefits | $68.7M | $63.2M | $63.8M | $64.3M |
| Occupancy and equipment | $15.8M | $14.9M | $14.8M | $14.0M |
| Data processing expense | $9.3M | $8.9M | $8.9M | $8.4M |
| Merger and acquisition expenses | $12.7M | $394.0K | — | — |
| Other operating expenses | $28.9M | $26.6M | $27.3M | $29.3M |
| Total non-interest expense | $135.5M | $114.0M | $114.8M | $116.0M |
| Income before income taxes | $154.4M | $152.2M | $159.3M | $152.0M |
| Income tax expense | $35.1M | $34.0M | $35.7M | $33.6M |
| Net income | $119.3M | $118.2M | $123.6M | $118.4M |
| Basic earnings per share (in dollars per share) | $0.59 | $0.60 | $0.63 | $0.60 |
| Diluted earnings per share (in dollars per share) | $0.59 | $0.60 | $0.63 | $0.60 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and due from banks | $237.2M | $281.1M | $226.4M | $263.9M |
| Interest-bearing deposits with other banks | $430.1M | $629.3M | $773.9M | $460.9M |
| Cash and cash equivalents | $667.3M | $910.3M | $1.0B | $724.8M |
| Federal funds sold | $3.0M | $3.7M | $5.1M | — |
| Estimated Fair Value | $2.9B | $3.1B | $3.5B | $4.0B |
| Investment securities — held-to-maturity, net of allowance for credit losses of $2,005 at both December 31, 2025 and 2024 | $1.3B | $1.3B | $1.3B | $1.3B |
| Total investment securities | $4.1B | $4.3B | $4.8B | $5.3B |
| Loans receivable | $15.7B | $14.8B | $14.4B | $14.4B |
| Allowance for credit losses | ($297.6M) | ($275.9M) | ($288.2M) | ($289.7M) |
| Loans receivable, net | $15.4B | $14.5B | $14.1B | $14.1B |
| Bank premises and equipment, net | $369.3M | $386.3M | $393.3M | $405.1M |
| Foreclosed assets held for sale | $39.8M | $43.4M | $30.5M | $546.0K |
| Cash value of life insurance | $220.5M | $219.8M | $214.5M | $213.7M |
| Accrued interest receivable | $108.9M | $120.1M | $119.0M | $103.2M |
| Deferred tax asset, net | $148.0M | $186.7M | $197.2M | $209.3M |
| Goodwill | $1.4B | $1.4B | $1.4B | $1.4B |
| Core deposit intangible | $32.3M | $40.3M | $48.8M | $58.5M |
| Other assets | $374.6M | $345.3M | $323.6M | $321.2M |
| Total assets | $22.9B | $22.5B | $22.7B | $22.9B |
| Demand and non-interest-bearing | $3.9B | $4.0B | $4.1B | $5.2B |
| Savings and interest-bearing transaction accounts | $11.8B | $11.3B | $11.1B | $11.7B |
| Time deposits | $1.8B | $1.8B | $1.7B | $1.0B |
| Total deposits | $17.5B | $17.1B | $16.8B | $17.9B |
| Securities sold under agreements to repurchase | $155.8M | $162.3M | $142.1M | $131.1M |
| FHLB and other borrowed funds | $500.3M | $600.8M | $1.3B | $650.0M |
| Accrued interest payable and other liabilities | $169.7M | $181.1M | $194.7M | $196.9M |
| Subordinated debentures | $279.3M | $439.2M | $439.8M | $440.4M |
| Total liabilities | $18.6B | $18.5B | $18.9B | $19.4B |
| Common stock, par value $0.01; shares authorized 400,000,000 in 2025 and 300,000,000 in 2024; shares issued and outstanding 196,357,167 in 2025 and 198,882,402 in 2024 | 2.0M | 2.0M | 2.0M | 2.0M |
| Capital surplus | $2.2B | $2.3B | $2.3B | $2.4B |
| Retained earnings | $2.3B | $1.9B | $1.7B | $1.4B |
| Accumulated other comprehensive loss | ($165.9M) | ($256.1M) | ($249.1M) | ($305.5M) |
| Total stockholders’ equity | $4.3B | $4.0B | $3.8B | $3.5B |
| Total liabilities and stockholders’ equity | $22.9B | $22.5B | $22.7B | $22.9B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and due from banks | $279.7M | $296.2M | $284.8M | $291.3M |
| Interest-bearing deposits with other banks | $772.9M | $815.7M | $516.2M | $809.7M |
| Cash and cash equivalents | $1.1B | $1.1B | $800.9M | $1.1B |
| Fed funds sold | $5.5M | $6.0M | $3.6M | $2.6M |
| Investment securities — available-for-sale, net of allowance for credit losses of $0 at both June 30, 2026 and December 31, 2025 (amortized cost of $2,997,415 and $3,088,820 at June 30, 2026 and December 31, 2025, respectively) | $2.8B | $2.8B | $2.9B | $2.9B |
| Investment securities — held-to-maturity, net of allowance for credit losses of $2,005 at both June 30, 2026 and December 31, 2025 | $1.3B | $1.3B | $1.3B | $1.3B |
| Total investment securities | $4.0B | $4.1B | $4.2B | $4.2B |
| Loans receivable | $17.1B | $15.6B | $15.3B | $15.2B |
| Allowance for credit losses | ($328.4M) | ($297.6M) | ($285.6M) | ($281.9M) |
| Loans receivable, net | $16.8B | $15.3B | $15.0B | $14.9B |
| Bank premises and equipment, net | $437.6M | $374.0M | $374.5M | $379.7M |
| Foreclosed assets held for sale | $42.1M | $40.9M | $41.3M | $41.5M |
| Cash value of life insurance | $233.5M | $221.8M | $219.1M | $218.1M |
| Accrued interest receivable | $108.4M | $106.6M | $110.7M | $107.7M |
| Deferred tax asset, net | $153.8M | $144.0M | $156.0M | $174.3M |
| Goodwill | $1.4B | $1.4B | $1.4B | $1.4B |
| Core deposit intangibles | $65.5M | $30.4M | $34.2M | $36.3M |
| Other assets | $374.3M | $371.3M | $380.2M | $383.4M |
| Total assets | $24.7B | $23.2B | $22.7B | $22.9B |
| Demand and non-interest-bearing | $4.4B | $4.0B | $3.9B | $4.0B |
| Savings and interest-bearing transaction accounts | $12.4B | $12.0B | $11.5B | $11.6B |
| Time deposits | $2.2B | $1.8B | $1.9B | $1.9B |
| Total deposits | $19.1B | $17.7B | $17.3B | $17.5B |
| Securities sold under agreements to repurchase | $158.7M | $157.4M | $146.0M | $140.8M |
| FHLB and other borrowed funds | $450.3M | $500.3M | $550.5M | $550.5M |
| Accrued interest payable and other liabilities | $164.1M | $176.7M | $189.6M | $203.0M |
| Subordinated debentures | $279.6M | $279.4M | $279.1M | $439.0M |
| Total liabilities | $20.2B | $18.9B | $18.5B | $18.8B |
| Common stock, par value $0.01; shares authorized 400,000,000 in 2026 and 2025; shares issued and outstanding 200,460,097 in 2026 and 196,357,167 in 2025 | 2.0M | 2.0M | 2.0M | 2.0M |
| Capital surplus | $2.3B | $2.2B | $2.2B | $2.2B |
| Retained earnings | $2.4B | $2.3B | $2.2B | $2.1B |
| Accumulated other comprehensive loss | ($169.0M) | ($179.4M) | ($183.1M) | ($235.9M) |
| Total stockholders’ equity | $4.5B | $4.3B | $4.2B | $4.1B |
| Total liabilities and stockholders’ equity | $24.7B | $23.2B | $22.7B | $22.9B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $475.4M | $402.2M | $392.9M | $305.3M |
| Depreciation & amortization | $29.2M | $29.2M | $30.9M | $31.9M |
| (Increase) decrease in value of equity securities | ($2.4M) | ($3.0M) | $1.1M | $1.3M |
| Increase in value of equity method investments | ($11.6M) | — | — | — |
| Amortization of securities, net | $12.8M | $14.4M | $16.5M | $20.3M |
| Accretion of purchased loans | ($5.1M) | ($8.1M) | ($10.6M) | ($16.3M) |
| Share-based compensation | $10.7M | $9.2M | $9.3M | $9.1M |
| Gain on assets | ($2.7M) | ($542.0K) | ($2.1M) | ($698.0K) |
| Gain on repurchase of subordinated debentures | ($1.9M) | — | — | — |
| Provision for credit losses - loans | $24.1M | $48.4M | $11.9M | $50.2M |
| Recovery of credit losses - unfunded commitments | ($1.0M) | — | — | — |
| Recovery of credit losses - investment securities | ($2.2M) | ($330.0K) | — | — |
| Deferred income taxes | $10.3M | $8.3M | ($4.1M) | $2.2M |
| Increase in cash value of life insurance | ($6.1M) | ($4.8M) | ($4.7M) | ($3.8M) |
| Originations of mortgage loans held for sale | ($737.2M) | ($630.2M) | ($480.8M) | ($510.1M) |
| Proceeds from sales of mortgage loans held for sale | $631.9M | $633.4M | $437.2M | $503.0M |
| Accrued interest receivable | $11.2M | ($1.2M) | ($15.8M) | ($24.5M) |
| Other assets | ($25.9M) | ($22.8M) | ($1.7M) | $9.3M |
| Accrued interest payable and other liabilities | ($10.3M) | ($13.6M) | ($724.0K) | $22.6M |
| Net cash provided by operating activities | $399.3M | $460.6M | $379.7M | $413.2M |
| Net decrease (increase) in federal funds sold | $725.0K | $1.4M | ($5.1M) | — |
| Net increase in loans | ($828.4M) | ($421.0M) | ($9.0M) | ($673.9M) |
| Purchases of investment securities – available-for-sale | ($113.8M) | ($64.1M) | ($9.9M) | ($1.3B) |
| Proceeds from maturities of investment securities – available-for-sale | $422.2M | $480.1M | $597.9M | $496.6M |
| Proceeds from maturities of investment securities – held-to-maturity | $16.3M | $7.0M | $5.9M | $501.5M |
| Purchases of equity securities | ($5.0M) | $0 | $0 | ($50.0M) |
| Proceeds from sales of equity securities | $2.4M | $3.4M | $1.5M | $13.8M |
| Purchases of other investments | $0 | $0 | ($3.4M) | ($60.9M) |
| Proceeds from redemption of other investments | $13.2M | $643.0K | — | — |
| OREO Improvements | ($3.5M) | — | — | — |
| Proceeds from foreclosed assets held for sale | $11.6M | $2.3M | $1.3M | $2.3M |
| Proceeds from sale of SBA loans | $10.6M | $8.5M | $4.0M | $4.3M |
| Purchases of premises and equipment | ($22.3M) | ($38.5M) | ($8.6M) | ($9.0M) |
| Proceeds from sales of premises and equipment | $18.8M | $26.3M | — | — |
| Return of (purchase of) investment on cash value of life insurance | $6.8M | ($346.0K) | — | — |
| Net cash (used in) provided by investing activities | ($470.3M) | $5.7M | $578.5M | ($1.0B) |
| Net increase (decrease) in deposits | $333.7M | $358.6M | ($1.2B) | ($2.2B) |
| Net (decrease) increase in securities sold under agreements to repurchase | ($6.5M) | $20.3M | $10.9M | ($9.7M) |
| Increase in FHLB and other borrowed funds | $0 | $1.4B | $6.5B | $601.0M |
| Decrease in FHLB and other borrowed funds | ($100.5M) | ($2.1B) | ($5.8B) | $0 |
| Retirement of subordinated debentures | ($158.0M) | $0 | $0 | ($300.0M) |
| Proceeds from exercise of stock options | $602.0K | $2.0M | $802.0K | $156.0K |
| Repurchase of common stock | ($82.2M) | ($86.5M) | ($48.8M) | ($70.9M) |
| Dividends paid on common stock | ($158.9M) | ($150.0M) | ($145.9M) | ($128.4M) |
| Net cash used in financing activities | ($172.0M) | ($556.2M) | ($682.7M) | ($2.3B) |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $237.5M | $118.2M | $357.2M | $233.6M |
| Depreciation & amortization | $16.0M | $7.5M | $21.7M | $14.3M |
| Decrease (increase) in value of equity securities | $431.0K | $1.2M | ($1.2M) | ($204.0K) |
| Increase in value of equity method investments | ($5.0M) | ($1.3M) | ($10.7M) | ($9.0M) |
| Amortization of securities, net | $5.2M | $3.0M | $9.9M | $6.5M |
| Accretion of purchased loans | ($3.6M) | ($1.1M) | ($3.9M) | ($2.6M) |
| Share-based compensation | $8.4M | $3.2M | $8.1M | $5.5M |
| Gain (loss) on assets | ($1.1M) | ($712.0K) | ($2.1M) | ($2.0M) |
| Provision for credit losses - loans | $6.7M | $1.5M | $9.7M | $3.0M |
| Recovery of credit losses - unfunded commitments | ($1.0M) | ($1.0M) | ($1.0M) | $0 |
| Deferred income tax effect | $5.0M | $8.2M | $7.7M | $5.4M |
| Increase in cash value of life insurance | ($2.9M) | ($1.4M) | ($4.7M) | ($3.3M) |
| Originations of mortgage loans held for sale | ($506.1M) | ($156.7M) | ($540.7M) | ($349.3M) |
| Proceeds from sales of mortgage loans held for sale | $490.4M | $158.8M | $475.4M | $293.1M |
| Accrued interest receivable | $5.9M | $2.3M | $9.4M | $12.4M |
| Other assets | $4.9M | $1.1M | ($29.7M) | ($34.1M) |
| Accrued interest payable and other liabilities | ($12.4M) | $8.0M | $9.5M | $21.9M |
| Net cash provided by operating activities | $248.3M | $150.8M | $310.6M | $195.4M |
| Net (increase) decrease in federal funds sold | ($2.5M) | ($3.0M) | $100.0K | $1.1M |
| Net decrease (increase) in loans, excluding purchased loans | $34.7M | $47.2M | ($460.6M) | ($361.1M) |
| Purchases of investment securities – available-for-sale | ($33.4M) | ($25.8M) | ($80.1M) | ($19.5M) |
| Proceeds from maturities of investment securities – available-for-sale | $222.7M | $73.1M | $315.5M | $212.7M |
| Proceeds from maturities of investment securities – held-to-maturity | $4.7M | $2.8M | $12.2M | $10.0M |
| Purchases of equity securities | $0 | — | ($5.0M) | ($5.0M) |
| Proceeds from sales of equity securities | $2.0M | — | — | — |
| Redemption of other investments | $1.7M | $2.3M | $11.7M | $10.2M |
| Purchases for improvements to foreclosed assets | $0 | ($161.0K) | ($2.9M) | ($2.7M) |
| Proceeds from sale of foreclosed assets | $9.1M | $1.5M | $8.4M | $7.0M |
| Proceeds from sale of SBA loans | $1.3M | $1.3M | $5.0M | $4.3M |
| Purchases of premises and equipment | ($14.9M) | ($11.6M) | ($17.8M) | ($14.9M) |
| Proceeds from sale of premises and equipment | $2.7M | $1.5M | $14.5M | $11.7M |
| Return of investment on cash value of life insurance, net | $331.0K | — | $6.8M | $6.2M |
| Net cash received - market acquisition | $88.2M | — | — | — |
| Net cash provided by (used in) investing activities | $316.4M | $89.0M | ($192.4M) | ($140.1M) |
| Net increase in deposits | $90.8M | $258.3M | $181.4M | $342.1M |
| Net increase (decrease) in securities sold under agreements to repurchase | $2.9M | $1.6M | ($16.4M) | ($21.5M) |
| Decrease in FHLB and other borrowed funds | ($135.0M) | $0 | ($50.3M) | ($50.3M) |
| Proceeds from exercise of stock options, net | $0 | $0 | $602.0K | $602.0K |
| Repurchase of common stock | ($54.7M) | ($13.9M) | ($67.3M) | ($57.3M) |
| Dividends paid on common stock | ($83.5M) | ($41.3M) | ($117.7M) | ($78.3M) |
| Net cash (used in) provided by financing activities | ($179.5M) | $204.7M | ($227.6M) | $135.4M |
| Net change in cash and cash equivalents | $385.2M | $444.6M | ($109.4M) | $190.7M |
| Cash and cash equivalents – beginning of year | $667.3M | $667.3M | $910.3M | $910.3M |
| Cash and cash equivalents – end of period | $1.1B | $1.1B | $800.9M | $1.1B |
HOME BANCSHARES INC score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.